Geron Corp (GERN.O)
GERN.O on Nasdaq
2.73USD
18 Aug 2016
2.73USD
18 Aug 2016
Change (% chg)
-- (+0.00%)
-- (+0.00%)
Prev Close
$2.73
$2.73
Open
$2.73
$2.73
Day's High
$2.76
$2.76
Day's Low
$2.68
$2.68
Volume
723,832
723,832
Avg. Vol
1,600,249
1,600,249
52-wk High
$5.30
$5.30
52-wk Low
$2.30
$2.30
GERN.O
About
Geron Corporation (Geron) is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, Inc. (Janssen). The Company operates through the segment, which includes discovery and development of therapeutic products for... (more)
Overall
| Beta: | 2.62 |
| Market Cap(Mil.): | $434.45 |
| Shares Outstanding(Mil.): | 159.14 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| GERN.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 741.85 | 37.70 | 36.40 |
| EPS (TTM): | 0.00 | -- | -- |
| ROI: | 1.00 | 0.17 | 14.12 |
| ROE: | 1.00 | -1.81 | 15.09 |
BRIEF-Geron Corp Q2 loss per share $0.05
* Geron corporation reports second quarter 2016 financial results and recent events
BRIEF-Geron announces issuance of U.S. patents related to Imetelstat
* Geron announces issuance of U.S. patents related to Imetelstat
BRIEF-Geron Corp reports Q1 loss per share $0.06
* Geron corporation reports first quarter 2016 financial results and recent events
Competitors
| Price | Chg | |
|---|---|---|
| Novartis AG (NOVN.S) | CHF78.45 | -0.10 |
| GlaxoSmithKline plc (GSK.L) | 1,674.50p | -6.00 |
| Bristol-Myers Squibb Co (BMY.N) | $58.68 | +0.38 |
| Bristol-Myers Squibb Co (BMYMP.PK) | $1,231.90 | -- |
| Gilead Sciences, Inc. (GILD.OQ) | $80.59 | -0.11 |
| Incyte Corporation (INCY.OQ) | $76.16 | -0.32 |
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider : Thomson Reuters Stock Report
|
$25.00
|
|
Provider : Stock Traders Daily
|
$20.00
|
|
Provider : New Constructs, LLC
|
$25.00
|
|
Provider : ValuEngine, Inc.
|
$25.00
|
|
Provider : S&P Capital IQ Quantitative Report
|
$104.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.